News

Amarantus claimed that MANF is a highly potent, neurotrophic factor currently in pre-clinical development for the treatment of a range of diseases that includes Parkinson’s disease. Amarantus said

Quick-Med’s patented technology, Nimbus is a antimicrobial technology that has been custom designed for wound care and other medical applications. Nimbus received de Novo FDA clearance in 2009

Caraco Pharma earned net income of $1.2m during the first quarter of Fiscal 2011, as compared to incurring a net loss of $9.4m during the corresponding period of

Mylan said that this new plan will generate 400 jobs in the northwest of the country, Mylan has stated that it has purchased a big hall of around

The kit combines Gentel’s APiX chromogenic detection platform and Clontech’s research-validated Antibody 380 array technology to help scientists study tumor-associated antigens, compare proteomic and transcriptomic data, and perform

The Chinese Letters Patent No 1758920 covers pharmaceutical compositions that comprise the greater and superior dosage size of chondroitin sulfate, and the use of those compositions for the

Hospira has posted 227.5% increase in net income to $83.5m for the second quarter 2010, or $0.49 per diluted share, compared to $25.5m, or $0.16 per diluted share,

MorphoSys has posted a net profit of EUR2.7m for the second quarter 2010 compared to net profit of EUR1.5m for the comparable period in 2009. Operating profit was

Methylphenidate is used to treat attention deficit disorder (ADD), attention deficit hyperactivity disorder (ADHD), and narcolepsy. Tris Pharma claimed that this is the first-ever generic ANDA approved by